Glutamate receptors on myelinated spinal cord axons: I. glur6 kainate receptors

Annals of Neurology

Volumn 65, Issue 2, 2009, Pages 151-159

  Ouardouz, Mohamed ^a   Coderre, Elaine ^a   Basak, Ajoy ^a   Chen, Andrew ^a   Zamponi, Gerald W ^b   Hameed, Shameed ^b   Rehak, Renata ^b   Xinghua, Yin ^b   Trapp, Bruce D ^c   Stys, Peter K ^b,d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LERNER RESEARCH INSTITUTE   (United States)

^d HRIC 1AA22 ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR 4; GLUTAMATE RECEPTOR 5; GLUTAMATE RECEPTOR 6; GLUTAMATE RECEPTOR 7; KAINIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NIMODIPINE; NITRIC OXIDE SYNTHASE; PDZ PROTEIN; RYANODINE; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPETITIVE INHIBITION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEREGULATION; EXTRACELLULAR SPACE; IMMUNOHISTOCHEMISTRY; LONG EVANS RAT; MALE; MOLECULAR MIMICRY; MYELINATED NERVE; NERVE FIBER; NERVE FIBER MEMBRANE; NONHUMAN; PDZ DOMAIN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; AXONS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CYSTEINE; EGTAZIC ACID; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HYDROXOCOBALAMIN; MALE; MICROSCOPY, CONFOCAL; MYOGLOBIN; NERVE FIBERS, MYELINATED; NITRIC OXIDE; PDZ DOMAINS; PEPTIDES; PROTEIN MULTIMERIZATION; RATS; RATS, LONG-EVANS; RECEPTORS, KAINIC ACID; RYANODINE; SPINAL CORD INJURIES; SPINAL NERVE ROOTS;

EID: 62549152683     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21533     Document Type: Article

References (51)

1. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway tor neurologic disorders. N Eagl J Med 1994:330:613-622.
2. + channels and Na+-Ca2+ exchanger. J Neurosci 1992:12: 430-439.
3. Fern R, Ransom BR, Waxman SG. Voltage-gated calcium channels in CNS white matter: role in anoxic injury. J Neuro-physiol 1995;74:369-377.
4. Imaizumi T, Kocsis JD, Waxman SG. Anoxic injury in the rat spinal cord - pharmacological evidence for multiple steps in Ca2+-dependent injury of the dorsal columns. J Neurotrauma 1997;14:299-311.
5. Stys PK. General mechanisms of axonal damage and irs prevenrion. J Neurol Sci 2005;233:3-13.
6. Agrawal SK, Fehlings MG. Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury. J Neurosci 1997;17:1055-1063.
7. Li S, Mealing GA, Morley P, et al. Novel injury mechanism in anoxia and trauma of spinal cord whire matter: glutamate release via reverse Na +-dependent glutamate transporr. J Neurosci 1999;19:RC16.
8. Ouardouz M, Malek S, Coderre E, et al. Complex interplay between glutamate receptors and intracellular Ca2+ stores during ischaemia in rat spinal cord white matter. J Physiol 2006; 577:191-204.
9. Tekkok SB, Goldberg MP. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci 2001;21:4237-4248.
10. Tekkok SB, Ye Z, Ransom BR. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 2007;1540-1552.
11. Kanellopoulos GK, Xu XM, Hsu CY, et al. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke 2000;31:1945-1952.
12. Wrathall JR, Choiniere D, Teng YD. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX. J Neurosci 1994;14:6598-6607.
13. Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000;6:67-70.
14. Smith T, Groom A, Zhu B, et al. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med 2000;6: 62-66.
15. McDonald JW, Althomsons SP, Hyrc KL, et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998;4:291-297.
16. Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci 2000;20:1190-1198.
17. Domercq M, Etxebarria K, Perez-Samartin A, et al. Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia 2005;52:36-46.
18. Matute C. Characteristics of acute and chronic kainate excitotoxic damage to the optic nerve. Proc Natl Acad Sci U S A 1998;95:10229-10234.
19. Fowler JH, McCracken E, Dewar D, et al. Intracerebral injection of AMPA causes axonal damage in vivo. Brain Res 2003; 991:104-112.
20. Matute C, Domercq M, Sanchez-Gomez MV. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 2006;53:212-224.
21. Karadottir R, Cavelier P. Bergersen LH, et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005;438:1162-1166.
22. Salter MG, Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005; 438:1167-1171.
23. Micu I, Coderre E, Jiang Q, et al. NMDA receprors mediate Ca accumulation in central nervous system myelin during chemical ischemia. Nature 2006;439:988-992.
24. David JC, Yamada KA, Bagwe MR, et al. AMPA receptor activation is rapidly toxic to cortical astrocytes when desensifization is blocked. J Neurosci 1996;16:200-209.
25. Matute C, Alberdi E, Domercq M, et al. Excitotoxic damage to white matter. J Anat 2007;210:693-702.
26. McCracken E, Fowler JH, Dewar D, et al. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J Cereb Blood Flow Metab 2002;22:1090-1097.
27. Verdoorn TA, Johansen TH, Drejer J, er al. Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur J Pharmacol 1994;269:43-49.
28. Mayer ML, Ghosal A, Dolman NP, et al. Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. J Neurosci 2006;26:2852-2861.
29. Donevan SD, Beg A, Gunther JM, et al. The methylglutamate, SY'M 2081, is a potent and highly selective agonist at kainate receptors, J Pharmacol Exp Ther 1998;285:539-545.
30. Ouardouz M, Nikolaeva M, Coderre E, et al. Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron 2003;40:53-63.
31. Rozas JL, Paternain AV, Lerma j. Noncanonical signaling by ionotropic kainate receptors. Neuron 2003;39:543-553.
32. Paternain AV, Cohen A, Stern-Bach Y, et al. A role for extracellular Na+ in the channel gating of native and recombinant kainate receptors. J Neurosci 2003;23:8641-8648.
33. McCarran WJ, Goldberg MP. White matter axon vulnerability to AMPA/kainate receptor-mediated ischemic injury is developmentally regulated. J Neurosci 2007;27:4220-4229.
34. Matute C, Alberdi E, Domercq M, et al. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 2001;24:224-230.
35. Flogel U, Merx MW, Godecke A, et al. Myoglobin: a scavenger of bioacrive NO. Proc Natl Acad Sci U S A 2001;98:735-740.
36. Rajanayagam MA, Li CG, Rand MJ. Differential effects of hy-droxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 1993;108:3-5.
37. Pinheiro P, Mulle C. Kainate receptors. Cell Tissue Res 2006; 326:457-482.
38. Stys PK, Ransom BR, Waxman SG. Compound action potential of nerve recorded by suction electrode: a theoretical and experimental analysis. Brain Res 1991;546:18-32.
39. Matute C, Sanchez-Gomez MV, Martinez-Millan L, et al, Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci U S A 1997;94:8830-8835.
40. Deng W, Rosenberg PA, Volpe JJ, et al. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci U S A 2003;100:6801-6806.
41. Ziskin JL, Nishiyama A, Rubio M, et al. Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 2007;10:321-330.
42. Kukley M, Capetillo-Zarate E, Dietrich D. Vesicular glutamate release from axons in white matter. Nat Neurosci 2007; 10: 311-320.
43. Semyanov A, Kullmann DM. Kainate recepror-dependent axonal depolarization and action potential initiation in interneurons. Nat Neurosci 2001;4:718-723.
44. Poliak S, Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 2003;4:968 -980.
45. Hart JD, Dulhunty AF, Nitric oxide activates or inhibits skeletal muscle ryanodine receptors depending on its concentration, membrane potential and ligand binding. J Membr Biol 2000; 173:227-236.
46. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
47. Yamada RX, Sasaki T, Ichikawa J, et al. Long-range axonal calcium sweep induces axon retraction. J Neurosci 2008;28: 4613-4618.
48. Aarts M, Liu Y, Liu L, er al. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 2002;298:846-850.
49. Liu XM, Pei DS, Guan QH, et al. Neuroprotection of Tat-GluR6 9c against neuronal death induced by kainate in rat hippocampus via nuclear and non-nuclear parkways. J Biol Chem 2006;281:17432-17445.
50. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338: 278-285.
51. Ouardouz M, Coderre E, Zamponi GW, et al, Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receprors. Ann Neurol 2009;65:160-166.